Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Neuberger Berman High Yield Strategies Fund Equity-to-Asset?
Neuberger Berman High Yield Strategies FundNHS 44 Equity-to-Asset is 0.67 as of Apr. 2026, which is 3% above its 10-year median of 0.65. GuruFocus rates NHS with a GF Score™ of 44/100 and a GF Value™ of $7.23 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 1,633 Asset Management companies, Neuberger Berman High Yield Strategies Fund ranks worse than 65.65% on this metric.
Neuberger Berman High Yield Strategies Fund (AMEX:NHS) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Neuberger Berman High Yield Strategies Fund Equity-to-Asset Related Terms
Neuberger Berman High Yield Strategies Fund Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neuberger Berman High Yield Strategies Fund Equity-to-Asset Chart
Neuberger Berman High Yield Strategies Fund Annual Data
For the Asset Management subindustry, Neuberger Berman High Yield Strategies Fund's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neuberger Berman High Yield Strategies Fund Equity-to-Asset vs Asset Management Industry
Neuberger Berman High Yield Strategies Fund Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neuberger Berman High Yield Strategies Fund (NHS) has a Equity-to-Asset of 0.67 as of Apr. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Neuberger Berman High Yield Strategies Fund and its competitors. This is near median its historical median of 0.65. Over the past decade, Neuberger Berman High Yield Strategies Fund's Equity-to-Asset has ranged from 0.56 to 0.72. According to the industry distribution chart, Neuberger Berman High Yield Strategies Fund ranks #1072 out of 1633 companies in the Asset Management industry, placing it in the top 65.6%.
Is Neuberger Berman High Yield Strategies Fund's Equity-to-Asset too high?
Neuberger Berman High Yield Strategies Fund's current Equity-to-Asset of 0.67 is near median its 10-year median of 0.65. Over the past 10 years, this metric has ranged from a low of 0.56 to a high of 0.72. The Asset Management industry median Equity-to-Asset is 0.83. Neuberger Berman High Yield Strategies Fund's value of 0.67 is 19.3% below this industry median. Based on the distribution chart, Neuberger Berman High Yield Strategies Fund ranks #1072 out of 1633 companies in the Asset Management industry, which is below the industry midpoint. Overall, Neuberger Berman High Yield Strategies Fund has a GF Score™ of 44/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Neuberger Berman High Yield Strategies Fund's Equity-to-Asset compare to CPZ and JRS?
According to the Asset Management industry distribution chart, Neuberger Berman High Yield Strategies Fund ranks #1072 out of 1633 companies for Equity-to-Asset. This places Neuberger Berman High Yield Strategies Fund in the lower half of its industry. The industry median Equity-to-Asset is 0.83. Neuberger Berman High Yield Strategies Fund's value of 0.67 is 19.3% below this benchmark. Historically, Neuberger Berman High Yield Strategies Fund's own Equity-to-Asset has ranged from 0.56 to 0.72 over the past decade. While the company's 10-year median is 0.65 vs. the industry median of 0.83, Neuberger Berman High Yield Strategies Fund has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for an Asset Management company?
The median Equity-to-Asset among Asset Management companies is 0.83, based on 1,633 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Neuberger Berman High Yield Strategies Fund's current Equity-to-Asset of 0.67 is 19.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Neuberger Berman High Yield Strategies Fund and its competitors. For the Asset Management industry, the median Equity-to-Asset is 0.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neuberger Berman High Yield Strategies Fund's current Equity-to-Asset is 0.67, which is near median its own 10-year median of 0.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neuberger Berman High Yield Strategies Fund stock overvalued right now?
Based on GuruFocus' analysis, Neuberger Berman High Yield Strategies Fund (NHS) is currently considered Modestly Undervalued. The stock's GF Value™ is $7.23, compared to a current price of $6.01 — trading 16.9% below its estimated fair value. The current Equity-to-Asset is 0.67, which is near median its 10-year median of 0.65 and 19.3% below the Asset Management industry median of 0.83. Neuberger Berman High Yield Strategies Fund's overall GF Score™ is 44/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Neuberger Berman High Yield Strategies Fund (NHS), the current Equity-to-Asset is 0.67 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Neuberger Berman High Yield Strategies Fund (NHS) Overvalued in 2026?
Based on GuruFocus' analysis, Neuberger Berman High Yield Strategies Fund stock appears to be undervalued.
The current stock price of $6.01 is trading 16.9% below its estimated GF Value™ of $7.23.
GuruFocus considers Neuberger Berman High Yield Strategies Fund to be Modestly Undervalued.
Key valuation signals for NHS:
Equity-to-Asset: 0.67 (near median its 10-year median of 0.65)
GF Value™: $7.23 vs. price of $6.01 (16.9% below fair value)
Industry Position: 19.3% below the Asset Management median (#1072 of 1633)
No single metric tells the full story. See the NHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Neuberger Berman High Yield Strategies Fund Inc is a diversified, closed-end management investment company. The company invests in high yield debt securities market. The Fund uses leverage to pursue its investment objective. The Fund may invest in a variety of direct debt instruments, including bank loans, notes and other interests in amounts owed to financial institutions by borrowers, such as companies and governments. Corporate loans in which the Fund may invest will consist of direct obligations of borrowers. The Fund may invest in corporate loans at origination as a co-lender or may acquire loans in the secondary market by purchasing participations in, assignments of or novations of corporate loans.
44GF Score
Get the complete analysis for NHS
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NHS has been successfully added to your 
